JOHN H POWERS III
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease
- Where
- OLNEY, MD
- NPI
- 1952540148
- Received
- $69,220 in 44 records, 2019 to 2025 ($65,345 general, $3,875 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 10 | $149 |
| 2024 | General payment | 1 | $28 |
| 2023 | General payment | 1 | $7,250 |
| 2022 | General payment | 5 | $14,878 |
| 2021 | General payment | 1 | $500 |
| 2020 | General payment | 7 | $14,282 |
| 2020 | Research payment | 1 | $1,250 |
| 2019 | General payment | 17 | $28,256 |
| 2019 | Research payment | 1 | $2,625 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $22,213 | 2019–2022 |
| Shionogi Inc | 9 | $16,800 | 2019–2023 |
| Gilead Sciences, Inc. | 4 | $14,634 | 2019–2020 |
| Romark Laboratories, LC | 2 | $3,875 | 2019–2020 |
| Amgen Inc. | 5 | $3,691 | 2019 |
| Celgene Corporation | 2 | $3,489 | 2020 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $2,812 | 2019–2020 |
| Bavarian Nordic A/S | 1 | $1,000 | 2020 |
| Celularity Inc. | 1 | $500 | 2021 |
| Abbott Laboratories | 11 | $177 | 2024–2025 |
| CVRx, Inc. | 1 | $25 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 16 | $58,055 |
| Travel and Lodging | 10 | $6,579 |
| Research payment | 2 | $3,875 |
| Food and Beverage | 16 | $710 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Abbott Laboratories | $21 | Food and Beverage | In-kind items and services | AVEIR Device, Structural Heart | 2025 | |
| 2025-11-11 | Abbott Laboratories | $23 | Food and Beverage | In-kind items and services | GALLANT Device, Structural Heart | 2025 | |
| 2025-07-03 | Abbott Laboratories | $24 | Food and Beverage | In-kind items and services | AVEIR Device, Structural Heart | 2025 | |
| 2025-07-03 | Abbott Laboratories | $10 | Food and Beverage | In-kind items and services | AVEIR Device, Structural Heart | 2025 | |
| 2025-07-03 | Abbott Laboratories | $10 | Food and Beverage | In-kind items and services | AVEIR Device, Structural Heart | 2025 | |
| 2025-07-03 | Abbott Laboratories | $3 | Food and Beverage | In-kind items and services | AVEIR Device, Structural Heart | 2025 | |
| 2025-06-27 | Abbott Laboratories | $16 | Food and Beverage | In-kind items and services | AVEIR Device, Structural Heart | 2025 | |
| 2025-06-23 | Abbott Laboratories | $9 | Food and Beverage | In-kind items and services | GALLANT Device, Structural Heart | 2025 | |
| 2025-06-23 | Abbott Laboratories | $8 | Food and Beverage | In-kind items and services | AVEIR Device, Structural Heart | 2025 | |
| 2025-02-13 | Abbott Laboratories | $20 | Food and Beverage | In-kind items and services | TENDRIL Device, Structural Heart | 2025 | |
| 2024-10-17 | Abbott Laboratories | $28 | Food and Beverage | In-kind items and services | MERLIN@HOME Device, Cardiac Rhythm Management | 2024 | |
| 2023-12-21 | Shionogi Inc | $7,250 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2022-10-04 | GlaxoSmithKline, LLC. | $811 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-09-07 | GlaxoSmithKline, LLC. | $2,434 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-07-10 | CVRx, Inc. | $25 | Food and Beverage | Cash or cash equivalent | Barostim Neo System Device, Heart Failure and Hypertension | 2022 | |
| 2022-02-09 | GlaxoSmithKline, LLC. | $8,607 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-01-18 | GlaxoSmithKline, LLC. | $3,000 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2021-01-28 | Celularity Inc. | $500 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2020-12-08 | Bavarian Nordic A/S | $1,000 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-05-20 | Gilead Sciences, Inc. | $2,040 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-04-27 | Gilead Sciences, Inc. | $3,060 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-03-11 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,012 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-02-19 | Romark Laboratories, LC | $1,250 | Research payment | Cash or cash equivalent | Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection | 2020 | |
| 2020-02-05 | GlaxoSmithKline, LLC. | $3,680 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2020-01-27 | Celgene Corporation | $132 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2020 | |
| 2020-01-25 | Celgene Corporation | $3,357 | Travel and Lodging | Cash or cash equivalent | 2020 | ||
| 2019-10-01 | GlaxoSmithKline, LLC. | $3,680 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-08-21 | Gilead Sciences, Inc. | $9,180 | Consulting Fee | Cash or cash equivalent | Descovy Drug, HIV | 2019 | |
| 2019-08-21 | Gilead Sciences, Inc. | $354 | Travel and Lodging | In-kind items and services | Descovy Drug, HIV | 2019 | |
| 2019-07-25 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,800 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-07-10 | Amgen Inc. | $2,000 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-07-10 | Amgen Inc. | $584 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-07-10 | Amgen Inc. | $577 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-07-10 | Amgen Inc. | $329 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-07-10 | Amgen Inc. | $199 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-06-20 | Romark Laboratories, LC | $2,625 | Research payment | Cash or cash equivalent | ALINIA Drug, GASTROENTEROLOGY | Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection | 2019 |
| 2019-06-12 | Shionogi Inc | $8,000 | Consulting Fee | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2019 | |
| 2019-03-20 | Shionogi Inc | $219 | Travel and Lodging | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2019 | |
| 2019-03-20 | Shionogi Inc | $125 | Food and Beverage | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2019 | |
| 2019-03-20 | Shionogi Inc | $67 | Travel and Lodging | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2019 | |
| 2019-03-20 | Shionogi Inc | $49 | Food and Beverage | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2019 | |
| 2019-03-19 | Shionogi Inc | $676 | Travel and Lodging | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2019 | |
| 2019-03-19 | Shionogi Inc | $262 | Travel and Lodging | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2019 | |
| 2019-03-19 | Shionogi Inc | $150 | Travel and Lodging | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Olney, MD, county Montgomery County, MD, state Maryland; placed by its city name.
| Measure | Place (city or town) Olney, MD | County Montgomery County, MD | State Maryland |
|---|---|---|---|
| Population B01003 | 35,797 | 1,065,949 | 6,206,011 |
| Population, 2020 census P1 | 35,820 | 1,062,061 | 6,177,224 |
| Median age B01002 | 41.6 | 40.2 | 39.4 |
| Under 18 B01001 | 26.2% | 22.8% | 22.2% |
| 65 and over B01001 | 16.5% | 17.0% | 16.7% |
| Households B11001 | 11,829 | 389,210 | 2,362,928 |
| Foreign born B05002 | 21.2% | 33.6% | 16.6% |
| Median household income B19013 | $171,458 | $132,450 | $103,678 |
| Median family income B19113 | $192,487 | $164,096 | $127,817 |
| Per capita income B19301 | $67,351 | $67,571 | $52,979 |
| Poverty rate B17001 | 4.3% | 7.5% | 9.4% |
| Unemployment rate B23025 | 3.6% | 4.9% | 4.9% |
| Civilian labor force B23025 | 19,305 | 590,776 | 3,313,651 |
| Mean commute (minutes) B08013 | 31.8 | 31.9 | 31.1 |
| Bachelor's degree or higher B15003 | 65.0% | 60.6% | 43.4% |
| Housing units B25001 | 12,060 | 406,531 | 2,560,784 |
| Owner-occupied B25003 | 89.2% | 65.3% | 67.6% |
| Renters B25003 | 10.8% | 34.7% | 32.4% |
| Median home value B25077 | $656,600 | $640,300 | $419,900 |
| Median gross rent B25064 | $2,404 | $2,068 | $1,705 |
| White, not Hispanic B03002 | 55.0% | 39.5% | 46.6% |
| Black B03002 | 14.4% | 18.3% | 28.9% |
| Hispanic or Latino B03002 | 12.1% | 21.0% | 12.5% |
| Asian B03002 | 11.6% | 15.3% | 6.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Olney, MD.
Comments